e-Blot
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
e-Blot - overview
Established
2017
Location
Shanghai, -, China
Primary Industry
Medical Devices & Equipment
About
Based in Shanghai, China and established in 2017, e-Blot is a medical company that provides imaging instrument for protein life science. The company was recognized as a high-tech enterprise in Shanghai. Tao Zhang, CEO of the company, has a Master's degree in Microbial Genetic Engineering from Chongqing University and has over 10 years of experience in the life science instrumentation industry. He was formerly the Application Marketing Manager & Regional Sales Manager of the Life Science Department in Jena, Germany.
The company's main business is bio-based material technology research and development, industrial enzyme preparation research and development, bio-chemical product technology research and development, instrumentation sales, and chemical product sales.
Current Investors
Anhui Guoyao Venture Capital Management
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Medical Devices & Equipment
Website
www.e-blot.com
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.